fashion -WSS

fashion

author：comprehensive 2025-09-30 17:59:26 - browse：72968

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Medicare isn't yet testing food as medicine

entertainment

WSS

David Sabatini, ex

Cholera vaccine supplies dangerously low, outbreaks surging

Medicare isn't yet testing food as medicine

Doctor of U.S. President Joe Biden says he is fit for duty

U.K. considers world's first use of meningitis vaccine to address gonorrhea

In key trial, Verve's treatment lowers cholesterol levels in patients

Wikipedia

fashion

entertainment

Apple is now the first public company to be valued at $3 trillion

Doctor of U.S. President Joe Biden says he is fit for duty

The cancer drug shortage isn’t new — and neither are the solutions

World's first CRISPR

Wildfire smoke exposes gaps in outdoor worker protections

Virtual repurposing can help discover new uses for existing drugs

In Memoriam: Notable people who died in 2023

Anthos stroke drug appears safer than common blood thinner

The high cost of giving birth even with insurance

Readout LOUD podcast: A CRISPR milestone, biotech mixology

explore

Cholera vaccine supplies dangerously low, outbreaks surging

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

PBM reforms clear House panel

Using force crossed my mind when examining a defiant young patient

hotspot

entertainment

leisure time

focus